Safety of Add on Aliskiren to Angiotensin Converting Enzyme Inhibitor (ACEI) and Angiotensin I Receptor Blocker (ARB) Treatment in Type 2 Diabetes With Nephropathy

This study is not yet open for participant recruitment.

Study NCT00949351 Information provided by Lerdsin General Hospital

First Received: July 29, 2009 No Changes Posted

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is not yet open for participant recruitment.
Estimated Study Completion Date:	September 2010
Estimated Primary Completion Date:	July 2010 (Final data collection date for primary outcome measure)